Dextromethadone
From Wikipedia, the free encyclopedia
Jump to navigation
Jump to search
| Names | |
|---|---|
| IUPAC name
(6S)-6-(Dimethylamino)-4,4-diphenylheptan-3-one
| |
| Other names
d-Methadone; 6S-Methadone; (+)-Methadone
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChemSpider | |
| ECHA InfoCard | 100.164.915 |
PubChem CID
|
|
| |
| |
| Properties | |
| C21H27NO | |
| Molar mass | 309.45 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
Dextromethadone is the (S)-enantiomer of methadone. Dextromethadone acts as a N-methyl-D-aspartate NMDA receptor antagonist.[1]
There is now an asymmetric synthesis[2] available to prepare both dextromethadone [S-(+)-methadone] and levomethadone [R-(−)-methadone].[3]
See also[edit]
References[edit]
- ^ Gorman AL, Elliott KJ, Inturrisi CE (Feb 14, 1997). "The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord". Neuroscience Letters. 223 (1): 5–8. PMID 9058409.CS1 maint: Uses authors parameter (link)
- ^ Hull JD, Scheinmann F, Turner NJ (March 2003). "Synthesis of optically active methadones, LAAM and bufuralol by lipase-catalysed acylations". Tetrahedron: Asymmetry. 14 (5): 567–576. doi:10.1016/S0957-4166(03)00019-3.
- ^ US patent 6143933
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |